National Health Act 1953 Amendment special arrangements under subsection 100(1) Chemotherapy Pharmaceuticals Access Program (No. PB 102 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 102 of 2008

Amendment special arrangements under subsection 100(1) of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.

Dated 2nd OCTOBER 2008

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program

1              Commencement

This instrument commences on 1 November 2008.

2              Amendment of PB 82 of 2008

Schedule 1 amends PB 82 of 2008.

Schedule 1        Amendments

1. Schedule 2, item dealing with Epirubicin

omit from the columns in the order indicated:

Powder for injection containing epirubicin hydrochloride 50 mg Injection/intravesical 4 . . Hospira Pty Limited

1. Schedule 2, item dealing with Irinotecan in the form I.V. injection
   containing irinotecan hydrochloride trihydrate 100 mg in 5 mL

in the column headed “Brand” insert in alphabetical order:

Irinotecan-GA